International asthma management guidelines often recommend inhaled short-acting b2 agonist therapy (as required) for this condition, since inhaled bronchodilators taken immediately prior to exercise effectively prevent the exercise-induced bronchoconstriction. However, this treatment does not influence the underlying airway hyperresponsiveness.